Author

Girish Kulkarni

Observed name: GIRISH KULKARNI

Institution: Torrent Pharma (India)

Observed institution: Torrent Pharma (India)

ORCID: 0000-0002-9507-0217

Observed ORCID: 0000-0002-9507-0217

OpenAlex ID: A5125279989

GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes

2026 · Kunal Zaveri, Girish Kulkarni, et al. · PLoS ONE · 1

1839-P: Real-World Effectiveness and Safety of Dapagliflozin/Glimepiride/Metformin Fixed-Dose Combinations (FDC) in Indian Adults with Type 2 Diabetes Mellitus (T2DM): Insights from BENEFACTOR Study

2026 · L. SREENIVASA MURTHY, SUPRATIK BHATTACHARYYA, et al. · Diabetes

Prescribing trends and clinical impact of calcium salt supplements in musculoskeletal pain: evidence from a multi-center retrospective analysis in India (TRACE study)

2026 · Reena J. Wani, Girish Kulkarni, et al. · BMC Musculoskeletal Disorders

Works count: 3

Citation count: 1

H-index: 1

I10-index: